Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $180.87 million. The enterprise value is $44.40 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 47.22 million shares outstanding. The number of shares has increased by 20.42% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 47.22M |
| Shares Change (YoY) | +20.42% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 32.92% |
| Owned by Institutions (%) | 37.51% |
| Float | 23.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.51 |
| Forward PS | n/a |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.81, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.81 |
| Quick Ratio | 7.96 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.17% and return on invested capital (ROIC) is -66.81%.
| Return on Equity (ROE) | -106.17% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -66.81% |
| Return on Capital Employed (ROCE) | -43.50% |
| Revenue Per Employee | $238,802 |
| Profits Per Employee | -$616,612 |
| Employee Count | 116 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SLN has paid $601,000 in taxes.
| Income Tax | 601,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.57% in the last 52 weeks. The beta is 1.19, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -81.57% |
| 50-Day Moving Average | 3.49 |
| 200-Day Moving Average | 10.31 |
| Relative Strength Index (RSI) | 59.35 |
| Average Volume (20 Days) | 240,832 |
Short Selling Information
| Short Interest | 1.47M |
| Short Previous Month | 1.62M |
| Short % of Shares Out | 3.11% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 5.79 |
Income Statement
In the last 12 months, SLN had revenue of $27.70 million and -$71.53 million in losses. Loss per share was -$1.52.
| Revenue | 27.70M |
| Gross Profit | 18.64M |
| Operating Income | -72.23M |
| Pretax Income | -52.45M |
| Net Income | -71.53M |
| EBITDA | -71.65M |
| EBIT | -72.23M |
| Loss Per Share | -$1.52 |
Full Income StatementBalance Sheet
The company has $136.53 million in cash and $60,000 in debt, giving a net cash position of $136.47 million or $2.89 per share.
| Cash & Cash Equivalents | 136.53M |
| Total Debt | 60,000 |
| Net Cash | 136.47M |
| Net Cash Per Share | $2.89 |
| Equity (Book Value) | 112.74M |
| Book Value Per Share | 2.39 |
| Working Capital | 150.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.81 million and capital expenditures -$215,000, giving a free cash flow of -$71.02 million.
| Operating Cash Flow | -70.81M |
| Capital Expenditures | -215,000 |
| Free Cash Flow | -71.02M |
| FCF Per Share | -$1.50 |
Full Cash Flow StatementMargins
Gross margin is 67.28%, with operating and profit margins of -260.73% and -258.21%.
| Gross Margin | 67.28% |
| Operating Margin | -260.73% |
| Pretax Margin | -256.04% |
| Profit Margin | -258.21% |
| EBITDA Margin | -258.64% |
| EBIT Margin | -260.73% |
| FCF Margin | n/a |